7.38
-0.81%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Alphatec Holdings
From its filings with the US Securities and Exchange Commission
Alphatec Holdings is based in Carlsbad, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker ATEC. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $764.2m and a net loss of $143.4m. At that date it held total assets of $791.2m and shareholders' equity of $12.4m.
We are a medical technology company, headquartered in Carlsbad, California, focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. By applying our unique, 100% spine focus and deep industry know-how, we aim to revolutionize spine surgery through clinical distinction. The sophisticated approaches that we create from the ground up integrate with our expanding InformatiX ("IX") platform to objectively inform surgery and achieve the goals of spine surgery more predictably and more reproducibly. We have a comprehensive product portfolio designed to address the spine’s various pathologies and we are perpetually innovating to accomplish our vision to be the standard bearer in spine.
Total revenue was $764.2 million for the year ended December 31, 2025, representing an increase of $152.6 million, or 25% compared to $611.6 million for the year ended December 31, 2024. We believe our future success will continue to be fueled by increasing surgeon adoption of our approach-specific procedures.
The year 2018 marked the beginning of a business transformation that replaced 100% of our executive team, 92% of our Board of Directors, and 96% of the remaining team with experienced professionals, infusing spine know-how throughout our organization. Efforts that year founded the ATEC Organic Innovation Machine, in-house product design, development and testing capabilities that harnessed the team’s collective spine expertise to create clinical distinction.
Quoted from its 10-K, filed 24 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 2 Jun 2006
- Employees
- 913
- Website
- alphatecspine.com ↗
- Head office
- 1950 CAMINO VIA ROBLE, CARLSBAD, CA
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Patrick MilesChairman of the Board, President, Chief Executive Officer, since 2017$6.2m
- Mr. J. Todd KoningChief Financial Officer, Executive Vice President$2.6m
- Mr. Scott LishChief Operating Officer$2.6m
- Mr. David SponselExecutive Vice President - Sales$2.8m
- Mr. Craig HunsakerExecutive Vice President - People and Culture$3.4m
- Mr. Ali ShorooghiSenior Vice President - Marketing
- Mr. Joseph WallandSenior Vice President - Imaging Solutions
- Mr. Tyson MarshallGeneral Counsel, Corporate Secretary
- Mr. Mortimer BerkowitzLead Independent Director, since 2005$234,597
- Mr. Evan BakstIndependent Director$227,907
- Mr. Quentin BlackfordIndependent Director$241,478
- Mr. David DemskiIndependent Director$1.3m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 52
- Environment
- 55
- Social
- 65
- Governance
- 34
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Alphatec Holdings Inc has a strong product portfolio, offering a wide range of innovative medical devices and technologies.
- The company has a well-established brand image and is recognized for its commitment to quality and patient safety.
- Alphatec Holdings Inc has a strong distribution network, allowing them to reach a large customer base and expand their market presence.
Weaknesses
- One of the weaknesses of Alphatec Holdings Inc is its heavy reliance on a limited number of key suppliers, which exposes the company to potential supply chain disruptions.
- The company faces intense competition in the medical device industry, which puts pressure on pricing and margins.
- Alphatec Holdings Inc has a relatively small market share compared to some of its larger competitors, limiting its market influence.
Opportunities
- The growing global aging population presents a significant opportunity for Alphatec Holdings Inc, as there is an increasing demand for medical devices and solutions to address age-related health issues.
- Expanding into emerging markets, where there is a rising focus on healthcare infrastructure development, could open new growth avenues for the company.
- Alphatec Holdings Inc could explore strategic partnerships or acquisitions to enhance its product offerings and expand its market reach.
Threats
- Increasing regulatory scrutiny and changes in healthcare policies pose a threat to Alphatec Holdings Inc, as it may lead to additional compliance requirements and affect pricing and reimbursement.
- The company is susceptible to economic downturns and fluctuations in healthcare spending, which could impact customer demand for medical devices.
- Competitors in the medical device industry are constantly innovating, which could pose a threat to Alphatec Holdings Inc's market position if it fails to keep up with the pace of technological advancements.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.